Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Doubling down on mRNA, BeiGene taps rising Hong Kong star to create targeted therapies
Fierce Biotech
Wed, 07/6/22 - 10:52 am
BeiGene
MRNA
drug discovery
Strand Therapeutics
InnoRNA
R&D
Medtech research spending set to slow in 2022
EP Vantage
Tue, 07/5/22 - 10:57 am
Medtech
R&D
Abbott Labs
Becton Dickinson
Boston Scientific
EssilorLuxottica
JNJ
Medtronic
Philips
Roche
Siemens Healthineers
Stryker
Bayer AG opens Kendall Square research center focused on cancer
Boston Globe, MA
Fri, 07/1/22 - 09:46 am
Bayer
Kendall Square
R&D
Boston
innovation
cancer
oncology
Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint
Endpoints
Thu, 06/30/22 - 12:07 pm
Heron Therapeutics
R&D
layoffs
restructuring
GSK pledges £1bn drive for infectious disease R&D
Pharmaforum
Fri, 06/24/22 - 10:23 am
GSK
R&D
infectious disease
Novartis pledges $250M in R&D funding for neglected tropical diseases, malaria
Endpoints
Thu, 06/23/22 - 10:37 am
Novartis
R&D
tropical diseases
malaria
neglected tropical diseases
Takeda to further cement presence in Cambridge, MA biopharma hub with 600,000-square-foot R&D center
Endpoints
Wed, 06/22/22 - 10:30 am
Takeda
biotech hubs
Cambridge MA
R&D
Boehringer Ingelheim to incubate biotechs with Hong Kong R&D leader
Endpoints
Fri, 06/17/22 - 09:51 am
Boehringer Ingelheim
R&D
Hong Kong
incubators
Research Shows Stem Cells Might Become a Game Changer for Multiple Sclerosis
BioSpace
Thu, 06/9/22 - 10:48 am
R&D
stem cells
multiple sclerosis
MS
Exclusive: Pfizer vet grabs $25M seed round to 'integrate' machine learning, genomics tech in drug R&D
Endpoints
Thu, 06/9/22 - 10:46 am
Pfizer
David Roblin
machine learning
funding
gemonics
R&D
Relation Therapeutics
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
Endpoints
Fri, 06/3/22 - 10:54 am
Boehringer Ingelheim
oncology
cancer
Singapore
R&D
Pfizer's new vaccine R&D leader Anderson has a high bar to reach in replacing Jansen
Fierce Pharma
Thu, 06/2/22 - 07:15 pm
Pfizer
R&D
vaccines
GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets
GSK said to be close to finding partner for science cluster in UK
Pharmaforum
Mon, 05/30/22 - 10:16 am
GSK
UK
R&D
Another biotech that went public in pandemic boom aims to weather the bear market through R&D cutbacks
Endpoints
Thu, 05/19/22 - 10:54 am
Nanobiotix
R&D
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Wed, 05/18/22 - 10:32 am
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
R&D
licensing
M&A
COVID-19
Big Pharma
Bristol Myers Squibb
JNJ
AbbVie
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Roche
GSK
Eli Lilly
Agios to cut jobs as it moves away from exploratory research
BioPharma Dive
Mon, 05/16/22 - 07:31 pm
Agios Pharmaceuticals
layoffs
R&D
A week after disclosing layoffs, BridgeBio nets a $90M upfront cancer R&D pact with Bristol Myers
Endpoints
Thu, 05/12/22 - 10:24 am
BridgeBio
Bristol Myers Squibb
cancer
R&D
Against a historic market downturn, Moma Therapeutics raises $150M for precision cancer research
BioPharma Dive
Wed, 05/11/22 - 10:51 am
MOMA Therapeutics
funding
R&D
cancer
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »